423 Stock Overview
Produces and sells Chinese medicine, health care products, and biological drugs in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥68.20 |
| 52 Week High | CN¥72.91 |
| 52 Week Low | CN¥44.52 |
| Beta | 0.67 |
| 1 Month Change | -0.90% |
| 3 Month Change | 22.05% |
| 1 Year Change | 42.08% |
| 3 Year Change | 92.00% |
| 5 Year Change | 66.67% |
| Change since IPO | 4,161.94% |
Recent News & Updates
Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21
Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Recent updates
Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results
Mar 25Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio
Mar 21Shareholder Returns
| 423 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.7% | -2.6% | 0.3% |
| 1Y | 42.1% | -11.9% | -9.8% |
Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -11.9% over the past year.
Return vs Market: 000423 exceeded the CN Market which returned -9.8% over the past year.
Price Volatility
| 423 volatility | |
|---|---|
| 423 Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.6% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 000423 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000423's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 3,678 | Jie Cheng | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China. It offers compound donkey-hide gelatin paste, Enwei compound Ejiao pulp, donkey-hide gelatin jujube, Ejiao Buxue granules, and collagen powders.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
| 423 fundamental statistics | |
|---|---|
| Market cap | CN¥43.92b |
| Earnings (TTM) | CN¥1.27b |
| Revenue (TTM) | CN¥5.10b |
34.5x
P/E Ratio8.6x
P/S RatioIs 423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 423 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.10b |
| Cost of Revenue | CN¥1.49b |
| Gross Profit | CN¥3.60b |
| Other Expenses | CN¥2.33b |
| Earnings | CN¥1.27b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.98 |
| Gross Margin | 70.69% |
| Net Profit Margin | 24.98% |
| Debt/Equity Ratio | 0% |
How did 423 perform over the long term?
See historical performance and comparison